These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1090 related articles for article (PubMed ID: 26105050)

  • 1. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ signaling and emerging opportunities for improved therapeutics.
    Wang S; Dougherty EJ; Danner RL
    Pharmacol Res; 2016 Sep; 111():76-85. PubMed ID: 27268145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxin activates peroxisome proliferator-activated receptor γ (PPARγ) through a pathway involving PPARγ coactivator 1α (PGC1α).
    Singh S; Simpson RL; Bennett RG
    J Biol Chem; 2015 Jan; 290(2):950-9. PubMed ID: 25389293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells.
    Kim HS; Hwang YC; Koo SH; Park KS; Lee MS; Kim KW; Lee MK
    PLoS One; 2013; 8(1):e50128. PubMed ID: 23372643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptor.
    Gras D; Chanez P; Urbach V; Vachier I; Godard P; Bonnans C
    Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L970-8. PubMed ID: 19346435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor gamma-independent activation of p38 MAPK by thiazolidinediones involves calcium/calmodulin-dependent protein kinase II and protein kinase R: correlation with endoplasmic reticulum stress.
    Gardner OS; Shiau CW; Chen CS; Graves LM
    J Biol Chem; 2005 Mar; 280(11):10109-18. PubMed ID: 15649892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide activation of peroxisome proliferator-activated receptor gamma through a p38 MAPK signaling pathway.
    Ptasinska A; Wang S; Zhang J; Wesley RA; Danner RL
    FASEB J; 2007 Mar; 21(3):950-61. PubMed ID: 17197391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
    Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
    Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxin signaling activates peroxisome proliferator-activated receptor gamma.
    Singh S; Bennett RG
    Mol Cell Endocrinol; 2010 Feb; 315(1-2):239-45. PubMed ID: 19712722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
    Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
    Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammation.
    Cho RL; Lin WN; Wang CY; Yang CC; Hsiao LD; Lin CC; Yang CM
    Biochem Pharmacol; 2018 Feb; 148():222-237. PubMed ID: 29309760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA; Mazzella LJ; Rupnow HL; Hart CM
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1α expression.
    Xu W; Guo T; Zhang Y; Jiang X; Zhang Y; Zen K; Yu B; Zhang CY
    Exp Cell Res; 2011 May; 317(8):1083-92. PubMed ID: 20955697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
    Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive correlation between PPARgamma/PGC-1alpha and gamma-GCS in lungs of rats and patients with chronic obstructive pulmonary disease.
    Li J; Dai A; Hu R; Zhu L; Tan S
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):603-14. PubMed ID: 20732852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs.
    Schinner S; Krätzner R; Baun D; Dickel C; Blume R; Oetjen E
    Br J Pharmacol; 2009 Jul; 157(5):736-45. PubMed ID: 19338578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways.
    Ji H; Wang H; Zhang F; Li X; Xiang L; Aiguo S
    Inflamm Res; 2010 Nov; 59(11):921-9. PubMed ID: 20495845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosiglitazone regulates c-reactive protein-induced inflammatory responses via glucocorticoid receptor-mediated inhibition of p38 mitogen-activated protein kinase-toll-like receptor 4 signal pathway in vascular smooth muscle cells.
    Liu N; Liu JT; Ji YY; Lu PP
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):348-56. PubMed ID: 21383592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators.
    Fujimura T; Sakuma H; Konishi S; Oe T; Hosogai N; Kimura C; Aramori I; Mutoh S
    J Pharmacol Sci; 2005 Dec; 99(4):342-52. PubMed ID: 16314690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.